Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria ; volume:15 ; number:1 ; day:2 ; month:10 ; year:2022 ; pages:1-4 ; date:12.2022
BMC Research Notes / Biomed Central; 15, Heft 1 (2.10.2022), 1-4, 12.2022
- Urheber
-
Tarning, Joel
Seidlein, Lorenz von
Dondorp, Arjen M.
White, Nicholas J.
Maude, Richard J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-022-06212-y
- URN
-
urn:nbn:de:101:1-2022122021081034858039
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tarning, Joel
- Seidlein, Lorenz von
- Dondorp, Arjen M.
- White, Nicholas J.
- Maude, Richard J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The fluid management of adults with severe malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Malaria parasite clearance
The role of anti-malarial drugs in eliminating malaria
Determinants of relapse periodicity in Plasmodium vivax malaria
The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The fluid management of adults with severe malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Malaria parasite clearance
The role of anti-malarial drugs in eliminating malaria
Determinants of relapse periodicity in Plasmodium vivax malaria
The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The fluid management of adults with severe malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Malaria parasite clearance
The role of anti-malarial drugs in eliminating malaria